Analytical Data
-
基因名
PSMD6
- Application
-
别名
S10; p44S10; Rpn7; PFAAP4; 26S proteasome regulatory subunit RPN7; Breast cancer-associated protein SGA-113M; Phosphonoformate immuno-associated protein 4
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q15008
-
表达区间
Met1~Met389
-
分子量
76kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PSMD6, a crucial component of the 26S proteasome complex, plays a vital role in protein degradation and regulation within eukaryotic cells. As a regulatory particle, PSMD6 is involved in the recognition and unfolding of ubiquitinated substrates, facilitating their translocation into the catalytic core of the proteasome for proteolytic degradation. Research into PSMD6 has gained significance due to its implications in various cellular processes, including cell cycle regulation, apoptosis, and the modulation of signaling pathways. Dysregulation of proteasomal activity, in which PSMD6 is implicated, has been linked to several diseases, including cancer and neurodegenerative disorders. Thus, the characterization of PSMD6, especially in its recombinant form, is crucial for understanding its functional mechanisms and potential roles in disease. Advances in recombinant protein technologies allow for the production and purification of PSMD6, enabling detailed studies of its structure-function relationships. Investigating PSMD6's interactions with other proteasomal subunits and cellular factors can provide insights into the overall proteasome function and its impact on cell homeostasis. Overall, the study of PSMD6 recombinant protein not only enhances our understanding of proteasomal dynamics but also opens avenues for therapeutic interventions in diseases associated with proteostasis imbalance.












